Sign In
Buy HALO
$69.82
+3.54 (+5.34%)
At Close: Jun 03, 2026
M&T Bank Corp Buys 5,130 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)
07:20am, Monday, 15'th Jun 2020
M&T Bank Corp lifted its stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) by 10.7% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission.
Analyzing Polarityte (NASDAQ:PTE) & Halozyme Therapeutics (NASDAQ:HALO)
03:18am, Sunday, 14'th Jun 2020
Polarityte (NASDAQ:PTE) and Halozyme Therapeutics (NASDAQ:HALO) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Janssen Research & Development, LLC (Janssen) presented data from its Phase III ANDROMEDA (AMY3001) study of subcutaneous (SC) daratumum
Why Is Halozyme Therapeutics (HALO) Up 1% Since Last Earnings Report?
03:30pm, Wednesday, 10'th Jun 2020
Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
First Trust Advisors LP Purchases New Shares in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
04:48am, Wednesday, 10'th Jun 2020
First Trust Advisors LP acquired a new stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange
Edited Transcript of HALO earnings conference call or presentation 11-May-20 8:30pm GMT
12:50pm, Monday, 08'th Jun 2020
Q1 2020 Halozyme Therapeutics Inc Earnings Call
Edited Transcript of HALO earnings conference call or presentation 11-May-20 8:30pm GMT
12:23pm, Friday, 05'th Jun 2020
Q1 2020 Halozyme Therapeutics Inc Earnings Call
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the European Commission (EC) has granted Janssen-Cilag International NV (Janssen) marketing authorization for the subcutaneous (SC) form
Is Halozyme Therapeutics (HALO) a Smart Long-term Buy?
02:28pm, Friday, 29'th May 2020
First Eagle Investment Management recently released its Q1 2020 Investor Letter, a copy of which you can download below. The First Eagle Fund of America posted a return of -23.72% for the quarter (wit
Halozyme To Present At Upcoming Virtual Investor Conferences
12:01pm, Thursday, 28'th May 2020
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Dr. Helen Torley, president and chief executive officer, will be participating in the following investor conferences:
Why Halozyme (HALO) Could Be Positioned for a Surge
12:32pm, Wednesday, 20'th May 2020
Halozyme (HALO) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
Canaccord Genuity Maintains Buy on Halozyme Therapeutics, Raises Price Target to $27
03:42pm, Tuesday, 19'th May 2020Why Halozyme (HALO) Stock Might be a Great Pick
12:37pm, Tuesday, 19'th May 2020
Halozyme (HALO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Top Ranked Momentum Stocks to Buy for May 15th
03:25pm, Friday, 15'th May 2020
Top Ranked Momentum Stocks to Buy for May 15th
